Gehrden, Germany

Dagmar Hoeltje

USPTO Granted Patents = 11 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 135(Granted Patents)


Location History:

  • Gronau, DE (1989 - 1995)
  • Gehrden, DE (1997 - 2008)

Company Filing History:


Years Active: 1989-2008

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Dagmar Hoeltje: Innovator in Pharmaceutical Compounds

Introduction

Dagmar Hoeltje is a prominent inventor based in Gehrden, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Dagmar Hoeltje holds a total of 11 patents. Her latest patents include Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds. These compounds exhibit neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity. They are particularly relevant for treating or inhibiting cardiovascular diseases, sexual dysfunction, and adverse conditions associated with apoptosis.

Career Highlights

Throughout her career, Dagmar has worked with notable companies such as Solvay Pharmaceuticals GmbH and Beecham-Wuelfing GmbH & Co. KG. Her work has significantly impacted the pharmaceutical industry, leading to advancements in drug development.

Collaborations

Dagmar has collaborated with esteemed colleagues, including Josef Messinger and Dietrich Thielke. These partnerships have fostered innovation and contributed to her success in the field.

Conclusion

Dagmar Hoeltje's work in pharmaceutical innovations showcases her dedication to improving health outcomes through her inventions. Her contributions continue to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…